Lallemand

United States Founded: 1915 • Age: 111 yrs
Microorganisms and derivatives are developed and marketed globally.
Annual revenue $750,685 Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors - Brand Intelligence

About Lallemand

Lallemand is a company based in United States founded in 1915. Lallemand has completed 3 acquisitions, including Evolva, Mascoma and Solyve.

  • Headquarter United States
  • Sectors
    Consumer
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Lallemand India Private Limited
  • Date of Incorporation 31 Oct, 2014
  • Jurisdiction Pune City, Maharashtra, India
Operational Areas
Consumer → Food & Beverage Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $750.69 K (USD)
    39.39
    as on Mar 31, 2024
  • Net Profit
    $4.34 K (USD)
    -91.03
    as on Mar 31, 2024
  • EBITDA
    $147.23 K (USD)
    -18.49
    as on Mar 31, 2024
  • Latest Funding Round
    $312.7 K (USD), Grant

    Dec 01, 2017

  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
    Evolva

    & 2 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

People of Lallemand

Headcount 1000-5000
Employee Profiles 75
Employee Profiles
People
Sylvie van Zandycke
Director Of Sales And Marketing Brewing Yeast
People
Diane MacPherson
Payroll & Benefits Administrator
People
Lis Nimani
Director Of Operations
People
Ayrton Cabrol
Strategic & Large Capex Project Engineer

Unlock access to complete

Funding Insights of Lallemand

Investors in Lallemand

Lallemand has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and OSTI.GOV.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Scientific and technical information is managed and disseminated by OSTI.GOV.
Locked Locked Locked
Premium access

Investor details for Lallemand

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Lallemand

Lallemand has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Evolva, Mascoma and Solyve.

Investments
Premium access

Investment portfolio details for Lallemand

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Enzymes and biosolutions are manufactured for food and beverage industries.
Locked Locked 2020 Locked
Advanced bioconversion products for bioethanol production are developed.
Locked Locked 2005 Locked
Producer of natural and functional ingredients for food, beverage and healthcare products
Locked Locked 2004 Locked
Premium access

Complete acquisition details for Lallemand

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Lallemand

Premium access

Detailed financials for Lallemand

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Lallemand Comparisons

Lallemand Primary company
Description
Microorganisms and derivatives are developed and marketed gl...
Location
United States
Founded Year
1915
Annual Revenue
$750.69 K (USD)
Net Profit
$4.34 K (USD)
EBITDA
$147.23 K (USD)
Employees
Not available
Premium access

Peer comparison for Lallemand

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Lallemand

Premium access

Detailed competitors of Lallemand

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Lallemand

Premium access

Complete news archive for Lallemand

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Lallemand

Lallemand was founded in 1915 and raised its 1st funding round 95 years after it was founded.

Lallemand is headquartered in United States.

Antoine Chagnon is the current CEO of Lallemand.

Annual revenue of Lallemand is $750.69K as on Mar 31, 2024.

The company was founded in 1915 and is headquartered in the United States. Microorganisms, including yeasts, bacteria, and fungi, along with their derivatives, are developed, produced, and marketed for applications in human and animal nutrition, baking, winemaking, brewing, food ingredients, probiotics, and biofuels. Support and expertise are offered alongside the products, utilizing a proprietary strain collection and research capabilities. Operations are structured into business units that address specific industry needs.

Lallemand has made 3 acquisitions, including Evolva, Mascoma, and Solyve.

Lallemand has 2 investors. Key investors include European Union, and OSTI.GOV.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available